文献速递血液净化与透析肾血管病与高血压水电解质与酸碱

透析液钾浓度对透析中高血压影响的随机试验

Randomized Trial on the Effects of Dialysate Potassium Concentration on Intradialytic Hypertension.
PubMed 文献 · Kidney Int Rep · 2023-04-11

这项在泰国两家医院进行的24周、多中心、双盲、随机交叉试验纳入40例频繁发生透析中高血压的稳定维持性血液透析患者,比较透析液钾2 mmol/l(D-K2)与3 mmol/l(D-K3)的影响。结果显示透析中高血压发生率D-K2组54.7% vs D-K3组53.1%,差异无统计学意义(P=0.788),收缩压、舒张压和平均动脉压变化两组间也无差异。

要点

  • 透析液钾2 mmol/l与3 mmol/l组透析中高血压发生率无显著差异(54.7% vs 53.1%,P=0.788)。
  • 两组的收缩压、舒张压和平均动脉压变化均无显著差异。
  • 研究纳入频繁发生透析中高血压的稳定维持性血液透析患者。

核心结论

  • 透析液钾浓度2或3 mmol/l不影响频繁发生透析中高血压的维持性血液透析患者的透析中高血压发生率。

研究设计与样本

  • 24周、2种治疗、4种序列、多中心、双盲、随机交叉研究,在泰国Maharaj Nakorn Chiang Mai医院和Lampang医院进行。
  • 纳入过去3个月内超过30%的透析 sessions 发生透析中高血压的稳定维持性血液透析患者,共40例。
  • 每例患者随机分配至4种治疗序列之一,每个干预期按预分配序列使用透析液钾2 mmol/l(D-K2)或3 mmol/l(D-K3)透析4周,期间间隔2周洗脱期。

主要发现

  • 平均年龄61.4 ± 14.2岁,平均收缩压146.6 ± 11.2 mm Hg。
  • 40例患者中95.5%有高血压,平均降压药数量为2.8 ± 1.9。
  • 共分析1380次透析 sessions(D-K2组695次,D-K3组685次)。
  • 透析中高血压发生率D-K2组54.7% vs D-K3组53.1%,差异无统计学意义(P = 0.788)。
  • 收缩压、舒张压和平均动脉压的变化在两种透析液钾浓度组间无差异。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Intradialytic hypertension is not an uncommon condition during chronic hemodialysis. It is associated with unfavorable cardiovascular outcomes, including hospitalization and mortality. Several small studies have demonstrated the contradictory effects of different dialysate potassium concentrations on intradialytic blood pressure. This study is a randomized crossover trial aiming to evaluate the effects of different dialysate potassium concentrations on intradialytic hypertension. METHODS: A 24-week, 2-treatment, 4-sequence, multicenter, double-blinded, randomized, crossover study was conducted at Maharaj Nakorn Chiang Mai Hospital and Lampang Hospital in Thailand among stable patients receiving chronic hemodialysis who experienced intradialytic hypertension >30% of their sessions over the past 3 months. Each participant was randomly assigned to 1 of 4 treatment sequences. During each intervention period, patients were dialyzed with dialysate potassium of either 2 mmol/l (D-K2) or 3 mmol/l (D-K3) for 4 weeks according to their preassigned sequence, separated by a 2-week washout period. The primary outcome was the incidence of intradialytic hypertension. RESULTS: Forty eligible patients were recruited. The mean age was 61.4 ± 14.2 years and the mean systolic blood pressure (SBP) was 146.6 ± 11.2 mm Hg. Of the 40 patients, 95.5% had hypertension and their average number of antihypertensive drugs was 2.8 ± 1.9. A total of 1380 dialysis sessions were included in the analysis (695 sessions for D-K2 and 685 sessions for D-K3). The incidence of intradialytic hypertension was not significantly different between different dialysate potassium concentrations (D-K2 54.7% vs. D-K3 53.1%, P = 0.788). The changes in SBP, diastolic blood pressure (DBP), and mean arterial pressure (MAP) were not different between the 2 dialysate potassium groups. CONCLUSION: Dialysate potassium concentration of 2 or 3 mmol/l did not affect the incidence of intradialytic hypertension in patients receiving chronic hemodialysis who frequently developed intradialytic hypertension.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Vongchaiudomchoke T, Aviphan K, Sanyakeun N, et al. Randomized Trial on the Effects of Dialysate Potassium Concentration on Intradialytic Hypertension. Kidney Int Rep. 2023. PMID: 37441490. doi:10.1016/j.ekir.2023.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。